2327 GMT - Corporate Travel Management is one of Morgans's key picks in the travel sector, despite its share price retracing close to levels achieved on the eve of its 1H result. Corporate Travel's stock bounced some 18% in value in the immediate aftermath of that result, which pointed to 35% growth in annual Ebitda. However, it has since fallen back to A$15.35. Morgans expects Corporate Travel to resume reporting strong earnings growth from 2H. "Corporate Travel is targeting a further 22% growth in Ebitda in FY 2026 based on A$1 billion of new client wins in FY 2025, the global rollout of Sleep Space will increase yield and its technology and automation projects are delivering solid margin expansion," Morgans says. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
March 06, 2025 18:27 ET (23:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.